Author/Authors :
abdelahi, m.m. mohamed mohammed v university rabat - centre de recherche des sciences des médicaments, pôle de compétences pharmacochimie, urac 21, faculté des sciences - laboratoire de chimie organique hétérocyclique, Rabat, Morocco , el bakri, y. mohammed v university rabat - centre de recherche des sciences des médicaments, pôle de compétences pharmacochimie, urac 21, faculté des sciences - laboratoire de chimie organique hétérocyclique, Rabat, Morocco , benchidmi, m. mohammed v university rabat - centre de recherche des sciences des médicaments, pôle de compétences pharmacochimie, urac 21, faculté des sciences - laboratoire de chimie organique hétérocyclique, Rabat, Morocco , essassi, e.m. mohammed v university rabat - centre de recherche des sciences des médicaments, pôle de compétences pharmacochimie, urac 21, faculté des sciences - laboratoire de chimie organique hétérocyclique, Rabat, Morocco , mague, j.t tulane university - department of chemistry, New Orleans, USA
Abstract :
In the present study, the title compound named as 3-chloro-6-nitro-1-(prop-2-en-1-yl)-1Hindazolewas synthesized by action of allyl bromide on 3-Chloro-6-nitroindazole. Thestructure of the compound obtained was established by single crystal X-ray analysis. Theasymmetric unit of the title compound, C10H8ClN3O2, contains two independent moleculesdiffering primarily in the orientations of the allyl substituents. The crystal packing involvesslipped π-stacking of indazole units together with weak C—H···O and C—H···Cl hydrogenbonds.
NaturalLanguageKeyword :
Crystal structure , hydrogen bond , π , stacking , indazole
